Similar Papers

Paper Title
Journal
Date
Author
A Review of the Potential of Phytochemicals from Prunus africana (Hook f.) Kalkman Stem Bark for Chemoprevention and Chemotherapy of Prostate Cancer.
Richard Komakech ... Jun-Hwan Lee
Evidence-Based Complementary and Alternative Medicine | VOL. 2017
Richard Komakech, et. al.Richard Komakech ... Jun-Hwan Lee
01 Jan 2017
Chemotherapy for prostate cancer: small steps or leaps and bounds? No huzzahs just yet!
D Raghavan
British Journal of Cancer | VOL. 91
D RaghavanD Raghavan
01 Sep 2004
Early chemotherapy in prostate cancer
Danish Mazhar ... Jonathan Waxman
Nature Clinical Practice Urology | VOL. 5
Danish Mazhar, et. al.Danish Mazhar ... Jonathan Waxman
01 Sep 2008
Clinical Trials of Low-Dose Metronomic Chemotherapy in Castration-Resistant Prostate Cancer
Keemo Delos Santos ... Urban Emmenegger
-
Keemo Delos Santos, et. al.Keemo Delos Santos ... Urban Emmenegger
01 Jan 2014
View more papers

More From: Nuclear Medicine and Biology

Paper Title
Journal
Date
Author
Characterization of a novel PET radioligand for mitochondrial complex I in nonhuman primate.
Yulong Xu ... Changning Wang
Nuclear medicine and biology | VOL. 142-143
Yulong Xu, et. al.Yulong Xu ... Changning Wang
01 Jan 2025
Production and purification of radiolabeling-ready 132/135La from the irradiation of metallic natBa targets with low energy protons.
E.S Kurakina ... V Radchenko
Nuclear medicine and biology | VOL. 144-145
E.S Kurakina, et. al.E.S Kurakina ... V Radchenko
01 Jan 2025
Preclinical evaluation of 68Ga-labeled folic acid conjugates for visualization of inflammatory foci.
Kristina A Petrosova ... Anton A Larenkov
Nuclear medicine and biology | VOL. 142-143
Kristina A Petrosova, et. al.Kristina A Petrosova ... Anton A Larenkov
01 Jan 2025
Alpha Atlas: Mapping global production of α-emitting radionuclides for targeted alpha therapy.
Marianna Tosato ... Valery Radchenko
Nuclear medicine and biology | VOL. 142-143
Marianna Tosato, et. al.Marianna Tosato ... Valery Radchenko
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.